×

Booming biotech: Alexion buys Synageva

4:40 AM ET Thu, 7 May 2015

Alexion has acquired Synageva Biopharma for over $8.4 billion. Ali Mortazavi, CEO at Silence Therapeutics, discusses possible reasons behind the deal.